Type 1 Diabetes: Symptoms, Treatment, and New Hope for a Cure, Part 2

Image

After diagnosis and the initiation of insulin therapy, some patients experience an unexpected improvement: glucose levels become more stable, and the need for injected insulin decreases noticeably. Sometimes this change is so pronounced that it creates the impression that diabetes is receding.

The Honeymoon Period in Type 1 Diabetes: Why Insulin Requirements Decrease After Treatment Begins

This phenomenon is called the “honeymoon period” of diabetes, or a period of partial remission.

The reason is that, at the time of diagnosis, not all pancreatic β-cells have necessarily been destroyed. Some are still capable of producing insulin, but before treatment begins, these cells function under an increased workload, while high glucose levels further impair their function.

When a patient begins receiving insulin, glucose levels decrease, the workload on the remaining β-cells is reduced, and they may temporarily recover some of their activity. As a result, the body begins producing more of its own insulin again, and the need for injections decreases.

Most interestingly, the remaining β-cells may still be capable of independently increasing insulin secretion after meals. Therefore, in some patients, even eating sweets may temporarily fail to cause a significant rise in glucose. This can create the impression that dietary restrictions are no longer necessary. However, this response varies between individuals: other patients may still need additional insulin before meals, even during partial remission.

The duration of the “honeymoon period” varies. In some patients, it lasts several months, while in others it may persist for a year or longer. Insulin requirements may change quite rapidly during this period, so doses need to be reviewed regularly to avoid hypoglycemia.

However, this reduction in insulin requirements does not mean that diabetes has been cured. The autoimmune process may continue, and the function of the remaining β-cells gradually declines. Therefore, even with very good glucose readings, insulin therapy should not be stopped independently. During this period, a C-peptide test can assess the remaining function of the β-cells, as discussed earlier, since C-peptide is released together with the body’s own insulin.

Nutrition in Type 1 Diabetes

Unlike the “honeymoon period” described above, we will now discuss nutrition in established type 1 diabetes, when the body’s own insulin production has significantly declined and it can no longer independently maintain normal glucose levels. Under these circumstances, it is especially important to match the amount and rate of carbohydrate absorption with the action of injected insulin.

At the same time, nutrition plays an important role not only in glucose control but also in supporting metabolism and the health of the vascular, nervous, and immune systems. Functional medicine places particular emphasis on food quality, adequate nutrient intake, the condition of the gut microbiome, and the reduction of chronic inflammation.

A well-designed diet should accomplish several goals simultaneously: provide the body with energy and nutrients, reduce sharp fluctuations in glucose after meals, and make the body’s response to food more predictable. The more accurately carbohydrate intake can be matched with insulin action, the easier it becomes to maintain glucose within the target range and reduce the risk of both hyperglycemia and hypoglycemia.

Principles of a Balanced Diet

The foundation of the diet may include vegetables, berries, fruits, legumes, whole grains, nuts, seeds, fish, eggs, meat, olive oil, and other predominantly minimally processed foods.

Several components are important when planning the diet:

  • Protein: essential for maintaining muscle mass, tissue repair, enzyme production, and normal immune function. Including protein in main meals also helps maintain satiety.
  • Healthy fats: particularly unsaturated fatty acids from fish, nuts, seeds, and olive oil. They are important for cell membranes, lipid metabolism, cardiovascular health, and the regulation of inflammatory processes.
  • Dietary fibre: found in vegetables, legumes, berries, and whole grains. It slows carbohydrate absorption, supports intestinal function, and provides nourishment for beneficial gut bacteria.
  • Vitamins and minerals: necessary for energy metabolism and the functioning of the nervous system, muscles, and immune cells.
  • Polyphenols and other plant compounds: found in berries, leafy greens, vegetables, tea, and many other plant foods; they are being studied in relation to oxidative stress and the protection of cells from damage.

Such a diet has an anti-inflammatory focus and helps support metabolic and cardiovascular health. However, not only the variety of foods but also their combinations throughout the day are important.

An anti-inflammatory diet does not mean that autoimmune destruction of pancreatic β-cells can be stopped through dietary changes. Its established role is primarily to support overall health and reduce risk factors for chronic complications.

Carbohydrates: How to Reduce Glucose Fluctuations

Carbohydrates have the most direct effect on the rise in glucose after meals. However, what matters is not only their quantity but also which foods they come from and how quickly they are absorbed.

For example, sugary drinks, white bread, and many products made from refined flour can cause a rapid rise in glucose. Legumes, certain whole grains, and foods rich in dietary fibre are generally absorbed more slowly and produce a more gradual glycemic response.

The glycemic index (GI) is used to compare carbohydrate-containing foods. It describes the rise in glucose after consuming a specified amount of carbohydrate from a food compared with a reference. The lower the GI, the smaller the rise in glucose generally observed when the amount of available carbohydrate is the same.

The concept of the glycemic index originated in Canada. In 1981, a group of researchers at the University of Toronto, led by Dr. David Jenkins, proposed using this measure to assess how different foods affect blood glucose levels. Today, Diabetes Canada provides special tables in which foods are classified as having a low, medium, or high glycemic index. These tables make it possible to compare different types of bread, grains, fruits, and other foods when planning a diet. Download the Diabetes Canada tables (PDF).

However, GI does not account for portion size. For this purpose, there is another measure called glycemic load (GL), which combines the glycemic index with the amount of available carbohydrate in the portion consumed. Therefore, even a food with a low GI can significantly increase glucose if consumed in large quantities.

This information is particularly useful when initially planning a diet, choosing alternatives to familiar foods, or identifying the causes of pronounced glucose fluctuations after certain meals.

Reducing the amount of rapidly absorbed carbohydrates and the overall carbohydrate load of meals helps limit sharp increases in glucose after eating and reduces the need for bolus insulin. At the same time, the diet should remain nutritionally complete, with adequate amounts of protein, healthy fats, and dietary fibre.

How to Coordinate Nutrition with Insulin Therapy

In type 1 diabetes, it is important that the entry of glucose from food into the bloodstream corresponds as closely as possible to the action of injected insulin.

If carbohydrates are absorbed very quickly, glucose may rise before insulin has had time to produce the necessary effect. Conversely, meals high in fat and protein can slow digestion and cause a delayed increase in glucose several hours after eating.

Therefore, not only carbohydrates themselves but also the composition of the entire meal, portion size, and meal timing are important. A relatively consistent amount of carbohydrate in regular meals and a predictable eating schedule can make it easier to coordinate the diet with insulin therapy.

Continuous glucose monitoring (CGM) systems make it possible to observe how the body responds to particular meals, how pronounced the increase in glucose is after eating, and whether delayed fluctuations occur. These data help evaluate an established diet and, when necessary, discuss adjustments with a physician.

If a diet provides complete nutrition and good glucose control, there is no need to change it solely to achieve a lower glycemic index. Significant changes in the amount or composition of carbohydrates may require adjustments to insulin doses and timing.

Nutrition and the Gut Microbiome

The condition of the gut microbiome is particularly important in functional medicine because intestinal microorganisms participate in metabolism, maintenance of the intestinal barrier, and regulation of immune responses.

A variety of plant foods rich in dietary fibre create favourable conditions for bacteria that produce short-chain fatty acids, including butyrate. Butyrate serves as an energy source for cells of the large intestine, helps maintain the integrity of the intestinal barrier, and participates in the regulation of inflammatory processes.

Thus, vegetables, legumes, berries, seeds, and other sources of dietary fibre are important not only for glycemic control but also for maintaining intestinal health and normal immune function.

Individual Food Tolerance

Even a well-balanced diet needs to be adapted to individual food tolerance. Gluten, a group of proteins found in wheat, rye, and barley, deserves particular attention. If there is reason to suspect that these foods cause bloating, abdominal pain, changes in bowel movements, or other unpleasant symptoms, it is reasonable to eliminate them from the diet and assess changes in how the person feels.

In type 1 diabetes, this issue is especially relevant because of an increased predisposition to other autoimmune diseases, particularly celiac disease and Hashimoto’s thyroiditis. These conditions share features of genetic predisposition and immune regulation.

The relationship between gluten and Hashimoto’s thyroiditis is of particular interest. Researchers are studying several possible mechanisms: changes in intestinal barrier permeability, activation of immune responses to gluten, and molecular mimicry, in which the immune system may cross-react with foreign proteins and the body’s own proteins. These mechanisms help explain a possible connection between the intestine and autoimmune processes in the thyroid gland.

In celiac disease, gluten causes autoimmune damage to the lining of the small intestine and must be completely eliminated. However, individual sensitivity to gluten may also exist without celiac disease. Therefore, when poor gluten tolerance is suspected, particularly in the presence of autoimmune diseases or a predisposition to Hashimoto’s thyroiditis, a trial elimination of gluten-containing foods may be a reasonable approach.

When transitioning to a gluten-free diet, it is important to maintain nutritional adequacy. Buckwheat, quinoa, rice, legumes, vegetables, and other naturally gluten-free foods can provide dietary variety. At the same time, the carbohydrate content of these foods and their effects on glucose should be considered, because changes to the usual diet may require adjustments to insulin therapy.

Ultimately, optimal nutrition in type 1 diabetes is a nutritionally complete diet that is well tolerated, provides the body with essential nutrients, supports long-term health, and makes it possible to maintain stable glucose levels when properly coordinated with insulin therapy.

What Supplements and Lifestyle Can Offer Beyond Insulin Therapy

In addition to a balanced diet, physical activity, adequate sleep, stress management, and a sufficient supply of essential nutrients play important roles in maintaining health with type 1 diabetes. These factors are interconnected and can influence insulin sensitivity, glucose fluctuations, the body’s recovery, and overall well-being.

Nutritional Supplementation

Vitamins, minerals, and other biologically active substances are necessary for normal body function. Some participate in protecting cells from damage, supporting the nervous system and muscle function, and regulating immune processes.

Particular attention is given to the following components:

  • Vitamin D: necessary for bone health and normal muscle and immune function. In people with type 1 diabetes, it is also studied in connection with autoimmune processes.
  • Magnesium: participates in muscle and nervous system function and energy production. When blood glucose remains elevated for a prolonged period, the body may lose more magnesium through urine. If a deficiency develops, it can negatively affect well-being.
  • Omega-3 fatty acids: found primarily in oily fish and involved in processes related to the regulation of inflammation. They are important for normal cellular function and cardiovascular health.
  • Vitamin B12: necessary for normal nervous system function and blood cell production. Deficiency may be accompanied by weakness, anemia, numbness, or tingling in the extremities. However, these symptoms may also be caused by diabetes itself.
  • Zinc: participates in immune function, tissue repair, and protection of cells from damage.
  • Alpha-lipoic acid: a substance involved in energy metabolism and the protection of cells from oxidative damage. It has been studied as a possible additional treatment for diabetic neuropathy, a form of nerve damage that may be accompanied by pain, burning, or tingling.
  • Probiotics and prebiotics: probiotics contain certain beneficial microorganisms, while prebiotics provide nourishment for certain intestinal bacteria.
  • Plant compounds: curcumin, quercetin, and green tea catechins are being studied as substances that may provide additional protection against inflammation and oxidative damage. Curcumin is being investigated in relation to vascular, kidney, and nervous system health; quercetin for the protection of nerve cells, the retina, and kidneys; and green tea catechins for supporting vascular health.

Physical Activity

Regular physical activity helps the body use glucose more effectively, increases tissue sensitivity to insulin, strengthens the heart and blood vessels, and supports muscle strength and bone health.

Different types of physical activity provide different benefits:

  • Aerobic exercise: walking, swimming, and cycling improve endurance, support cardiovascular health, and usually contribute to a decrease in glucose during exercise.
  • Strength training: helps maintain muscle mass and strength, supports metabolism and bone health.
  • Everyday movement: walking, taking the stairs, and regular breaks from sedentary work reduce the amount of time spent sitting.
  • Balance and flexibility exercises: help maintain mobility and are particularly beneficial for older adults or people at increased risk of falling.

In type 1 diabetes, it is important to consider that different forms of exercise can affect glucose differently. During aerobic exercise, glucose levels more often decrease, while short periods of intense activity may sometimes cause a temporary increase due to the release of adrenaline.

After exercise, insulin sensitivity may remain increased for several more hours. Therefore, glucose may sometimes decrease late in the evening or overnight, which needs to be considered when planning meals and insulin doses to prevent hypoglycemia.

Particular caution is needed when marked hyperglycemia is accompanied by insulin deficiency and elevated ketone levels. Under these circumstances, physical activity may increase ketone production and worsen metabolic disturbances, potentially leading to diabetic ketoacidosis. Therefore, when ketones are elevated, exercise should be postponed, and the individual plan for correcting hyperglycemia and ketosis should be followed.

Stress and Its Effect on Blood Glucose

When a person experiences anxiety, significant emotional tension, or chronic fatigue, the body releases stress hormones, primarily cortisol and adrenaline. These hormones help the body cope with demands but can also contribute to increased glucose levels and temporarily reduce tissue sensitivity to insulin.

This is why some people experience a rise in blood glucose during emotional stress, even when their diet and insulin doses have not changed.

However, the response varies between individuals. Stress can also affect appetite, sleep quality, physical activity, and the ability to manage diabetes consistently.

The following may help reduce stress:

  • Breathing exercises: help reduce feelings of tension and promote calmness.
  • Walking and moderate physical activity: help improve mood and emotional well-being.
  • Meditation and relaxation: may reduce anxiety and help people cope with everyday stress.
  • Regular rest: helps prevent the accumulation of fatigue.
  • Psychological support: is especially important in cases of persistent anxiety, fear of hypoglycemia, or emotional exhaustion.

The fatigue associated with managing diabetes itself deserves special attention. The constant need to measure glucose, calculate insulin doses, plan meals, and worry about hypoglycemia can cause considerable emotional strain.

This condition is sometimes called diabetes distress. It does not mean that a person is not trying hard enough to manage the condition. It is a psychological burden that can accumulate over the course of living with diabetes.

Sleep and Recovery

Adequate sleep is necessary for normal nervous and immune system function, recovery, and regulation of metabolism.

Insufficient sleep can increase stress hormone levels, intensify hunger, alter insulin sensitivity, and make glucose control more difficult.

In type 1 diabetes, sleep may sometimes be disrupted by nighttime glucose fluctuations, glucose sensor alarms, or anxiety about possible hypoglycemia.

Particular attention should be given to the following habits:

  • Regular schedule: try to go to bed and wake up at approximately the same time.
  • Adequate sleep duration: most adults need approximately 7–9 hours of sleep, although individual needs may vary.
  • Daylight and movement: help the body maintain its natural sleep-wake rhythm.
  • Evening relaxation: reducing exposure to bright light, late caffeine consumption, and emotionally stimulating activities may make it easier to fall asleep.
  • Monitoring nighttime glucose fluctuations: if sleep is regularly disrupted by hypoglycemia or monitoring alarms, the situation should be discussed with a physician.

Persistent insomnia, pronounced snoring, pauses in breathing during sleep, or severe daytime sleepiness warrant investigation to determine their causes.

How to Prevent Long-Term Complications of Type 1 Diabetes

Elevated blood glucose is dangerous because it can silently damage organs and tissues over many years, even when a person feels well. Because blood supplies the entire body, the consequences of chronic hyperglycemia can affect blood vessels, eyes, kidneys, heart, brain, and nervous system.

One mechanism of this damage is glycation, in which glucose reacts chemically with proteins and other molecules, altering their properties. The resulting advanced glycation end products (AGEs) accumulate in tissues and contribute to inflammation. At the same time, excess glucose increases oxidative stress, damages the inner lining of blood vessels, and disrupts blood flow. Gradually, both small capillaries and large arteries are affected.

The main danger of chronic hyperglycemia is its gradual, often symptomless damaging effect.

However, even properly adjusted insulin therapy cannot fully reproduce the function of a healthy pancreas. Insulin injected under the skin acts with a delay, so glucose fluctuations after meals, during physical activity, under stress, and during sleep are practically inevitable. Insulin pumps and continuous glucose monitoring systems help reduce these fluctuations, while good glucose control significantly lowers the risk of complications, although it does not eliminate it entirely.

At the same time, excessive lowering of glucose is also dangerous. Severe hypoglycemia can cause confusion, seizures, loss of consciousness, and, in exceptional cases, brain injury. Repeated episodes can weaken the ability to recognize impending hypoglycemia, increasing the risk of recurrence.

Therefore, in patients with frequent severe hypoglycemia, impaired awareness of hypoglycemia, cognitive disorders, significant frailty in old age, or serious coexisting illnesses, physicians may establish less stringent glucose targets. This does not mean that elevated blood glucose is beneficial: the goal is to prevent dangerously low glucose levels.

Optimal diabetes management is a balance between reducing the risk of long-term complications and preventing severe hypoglycemia. Therefore, glucose targets are individualized.

Which Organs Are Most Commonly Affected?

Eyes. The retina contains numerous tiny blood vessels that are particularly sensitive to chronic hyperglycemia. Damage to these vessels leads to diabetic retinopathy, which can gradually impair vision and, in severe cases, cause blindness. Early changes often occur without symptoms, so regular retinal examinations are necessary even when vision is good. When detected early, effective treatments are available, including laser therapy and injections of medication into the eye.

Kidneys. Prolonged exposure to elevated glucose damages the small blood vessels of the kidney glomeruli, gradually impairing the kidneys’ ability to filter blood. One early sign is increased excretion of albumin in the urine. Kidney health is assessed using the urine albumin-to-creatinine ratio (ACR) and blood creatinine with calculation of the estimated glomerular filtration rate (eGFR). These tests can identify abnormalities before symptoms appear.

Nervous system. Elevated glucose damages nerve fibres and the small blood vessels that supply them. Diabetic neuropathy most often begins in the feet and causes tingling, burning, pain, or numbness. Loss of sensation is particularly dangerous because a person may not notice minor injuries or skin damage, increasing the risk of ulcers and serious complications.

Diabetes can also damage the nerves that regulate internal organ function. This condition is called autonomic neuropathy. It can cause disturbances in digestion, urination, heart rhythm, and blood pressure regulation.

Heart and blood vessels. Chronic hyperglycemia damages the vascular wall and contributes to the accelerated development of atherosclerosis, increasing the risk of heart attack, stroke, and impaired circulation in the extremities. The combination of elevated glucose and high blood pressure is particularly dangerous because these factors together intensify vascular damage, including damage to blood vessels in the kidneys and retina.

This is why diabetes management traditionally places particular emphasis on stricter blood pressure control. For most adults with diabetes and hypertension, a target below 130/80 mmHg is used if well tolerated. Lower individualized targets may also be considered in patients with high cardiovascular or kidney risk.

What Else Helps Reduce the Risk of Complications?

There are everyday measures that help protect blood vessels and reduce the risk of complications of type 1 diabetes.

It is especially important to stop smoking. Tobacco smoke damages the inner lining of blood vessels, increases inflammatory processes, and contributes to the development of atherosclerosis. In diabetes, when blood vessels are already under increased strain due to glucose fluctuations, smoking further increases the risk of heart attack, stroke, circulation problems in the legs, and kidney damage.

Daily foot care is equally important. With diabetic neuropathy, sensation may gradually decrease, so minor cuts, calluses, and skin injuries sometimes go unnoticed. Regular foot inspection, comfortable footwear, and timely medical attention when wounds appear help prevent ulcers and infections.

Oral health also deserves special attention. People with diabetes have an increased risk of gum disease, particularly when glucose control is inadequate. Inflammation of the tissues surrounding the teeth, in turn, can make blood glucose management more difficult. Therefore, regular oral hygiene and preventive dental examinations are also part of comprehensive health care.

Which Examinations Are Important to Have Regularly?

Because many complications of diabetes develop gradually and remain symptomless for a long time, regular examinations are an essential part of treatment.

In addition to monitoring HbA1c and glucose monitoring data, the follow-up program includes:

  • Retinal examination for early detection of diabetic retinopathy. According to Diabetes Canada, regular screening is generally recommended beginning five years after the onset of type 1 diabetes in patients aged 15 years and older. Thereafter, examinations are usually performed annually, although the interval may sometimes be extended when retinopathy is absent and diabetes is well controlled;
  • Assessment of kidney function - a blood creatinine test with calculation of eGFR and a urine albumin-to-creatinine ratio (ACR). According to the updated Diabetes Canada 2025 guidelines, annual screening in type 1 diabetes generally begins five years after disease onset and, when diabetes develops in early childhood, after the onset of puberty;
  • Foot examination and nervous system assessment, including checks of sensation, skin condition, and circulation. Routine screening for diabetic neuropathy generally begins five years after diagnosis, but examinations are performed earlier if symptoms appear;
  • Monitoring blood pressure and lipid profile to assess cardiovascular risk. Blood pressure is checked regularly, while the frequency of cholesterol testing is determined according to age and other risk factors;
  • Screening for associated autoimmune diseases, primarily Hashimoto’s thyroiditis and celiac disease, according to clinical indications.

For children and adolescents, the recommended timing of screening may differ from that for adults. During pregnancy, when symptoms develop, or when complications have already been identified, an individualized monitoring schedule is also required.

The main purpose of regular examinations is to identify organ damage at an early stage, when opportunities still exist to slow its progression and prevent the most serious consequences.

Can the Body’s Own Insulin Production Be Restored?

Until quite recently, the possibility of restoring insulin production in type 1 diabetes seemed like a distant prospect. Today, this has already been achieved in individual patients. Moreover, some of them have been able to completely discontinue daily insulin injections after transplantation of pancreatic cells.

The idea is to replace destroyed β-cells with new cells capable of producing insulin independently in response to rising glucose levels. For this purpose, researchers use islet cells from a donor pancreas or cells grown in a laboratory from stem cells.

Particularly interesting is the fact that a substantial part of the history of this research is connected with Canada.

Edmonton: The First Successes of Islet Cell Transplantation

In 2000, a team at the University of Alberta led by Professor James Shapiro introduced a method known as the “Edmonton Protocol.” Transplantation of donor islet cells allowed patients with type 1 diabetes to restore insulin production, and some were able to stop insulin injections completely.

Over the past 25 years, Edmonton has become one of the world’s leading centres for islet cell transplantation. Today, this method is already used in specialized treatment programs for patients with severe hypoglycemia and difficult-to-control diabetes. Even when complete independence from insulin cannot be achieved, transplanted cells can significantly improve glucose stability and reduce the risk of dangerous complications.

Vancouver: New Cells Grown from Stem Cells

The next major achievement was the ability to grow insulin-producing cells in the laboratory without relying exclusively on donor organs.

At Vancouver General Hospital, a study of VX-880 (zimislecel), containing such cells, was conducted under the direction of Dr. Breay Paty. According to information published by BC Diabetes in 2026, one patient has been able to live without insulin injections for more than three years after transplantation. Another participant, who received cell therapy in September 2025, experienced a substantial reduction in insulin requirements.

In a larger study of this technology, 10 out of 12 patients who received the full dose of the cell product were able to discontinue insulin one year after transplantation.

These results demonstrate that even many years after the destruction of the body’s own β-cells, the ability to produce insulin can be restored.

Why Can’t New Cells Simply Be Transplanted into Every Patient?

The main problem lies in the immune system, and there are two different mechanisms involved.

If the cells come from a donor or are grown from a foreign cell line, the immune system recognizes them as foreign and attempts to destroy them. The same process occurs with transplantation of a kidney, liver, or another organ. To prevent rejection, the patient must take medications that suppress the immune system.

If new β-cells are grown from the patient’s own tissues, conventional rejection of foreign tissue can be avoided. However, the original autoimmune disease remains. The immune system that once destroyed the patient’s own pancreatic β-cells can also attack the newly grown cells because they possess the same characteristic structures.

Suppressing the immune system helps protect the transplant but carries serious risks. Immunosuppressive medications increase susceptibility to infections, including severe fungal and viral infections. Some can damage the kidneys, increase blood pressure, and disrupt lipid metabolism. Long-term use also increases the risk of certain cancers. Therefore, the need for many years of immunosuppression substantially limits the use of cell therapy in people who successfully manage diabetes with modern treatments.

Who May Be Eligible for Transplantation in Canada?

In Canada, transplantation of donor islet cells is already performed at specialized centres, while transplantation of stem cell-derived cells is still conducted as part of clinical trials.

The main criterion for selecting patients is the balance between the expected benefits and risks of transplantation, particularly those associated with the need for long-term immunosuppression. Therefore, the most suitable candidates are considered to be adults with long-standing type 1 diabetes who continue to experience recurrent severe hypoglycemia, have impaired awareness of its onset, or face serious difficulties controlling glucose despite modern treatment.

Patient selection takes into account age, overall health, kidney function, and coexisting medical conditions. Younger age alone does not guarantee better engraftment of donor islet cells. A special group consists of patients who are already receiving immunosuppressive medications after a kidney transplant, because they require such treatment regardless of islet cell transplantation.

In British Columbia, the possibility of a referral for transplantation can be discussed with an endocrinologist. Additional information: BC Diabetes, University of Alberta and BC Transplant.

What Can We Expect in the Future?

Today, researchers are working on developing cells that can function without continuous suppression of the immune system. One approach involves placing islet cells inside protective implants that allow glucose and insulin to pass through while preventing immune cells from entering. Another involves genetically modifying transplanted cells to make them less visible to the immune system.

Early clinical studies have already demonstrated that these modified cells can maintain insulin production without systemic immunosuppression. Their numbers are not yet sufficient to meet the body’s full insulin requirements, but the preservation of transplant function itself represents an important step forward.

Thus, it has now been demonstrated that insulin production can be restored even after many years of type 1 diabetes. However, the challenge for the future is to learn how to protect new β-cells from the immune system without requiring lifelong immunosuppressive medications.

Conclusion

In just over a hundred years, medicine has made enormous progress in the treatment of type 1 diabetes. A disease that almost inevitably led to death before the discovery of insulin has become a chronic condition with which people can live for decades, start families, work, and lead active lives.

However, type 1 diabetes still requires constant attention. Even the most advanced medications and technologies cannot fully reproduce the function of a healthy pancreas. Glucose fluctuations, the risk of hypoglycemia, and progressive damage to blood vessels and other tissues remain serious problems. Therefore, successful treatment involves not only controlling blood glucose measurements but also preserving a person’s health, independence, and quality of life.

At the same time, we are witnessing an important turning point in the development of medicine. For the first time, researchers have been able not merely to compensate for a lack of insulin but to restore its production in people who have lived with type 1 diabetes for many years. For now, these methods are associated with serious limitations, particularly the need to protect transplanted cells from the immune system.

And yet, the central question is gradually changing. While previously the primary concern was how to learn to live with diabetes, today scientists are increasingly seeking an answer to a different question: how can we restore a person’s ability to produce insulin independently without exposing them to additional risks? Solving this problem may become the next major achievement in the history of type 1 diabetes treatment.


Jones D. S., ed. Textbook of Functional Medicine. 3rd ed. Institute for Functional Medicine, 2010. ISBN 9780977371372.

Institute for Functional Medicine. Type 1 Diabetes and Multimorbidity. Updated March 10, 2026.

Sievenpiper J. L. et al. Nutrition Therapy. Canadian Journal of Diabetes, 2018.

Jenkins D. J. A. et al. Glycemic Index of Foods: A Physiological Basis for Carbohydrate Exchange. American Journal of Clinical Nutrition, 1981.

Diabetes Canada. The Glycemic Index Guide. PDF.

Levran N. et al. The Mediterranean Diet for Adolescents with Type 1 Diabetes: A Prospective Interventional Study. Nutrients, 2023.

Levran N. et al. Low-Carbohydrate Diet Proved Effective and Safe for Youths with Type 1 Diabetes: A Randomised Trial. Acta Paediatrica, 2025.

Araújo E. M. Q. et al. Effects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis. Nutrients, 2025.

Baicus C. et al. Alpha-Lipoic Acid for Diabetic Peripheral Neuropathy. Cochrane Database of Systematic Reviews, 2024.

Halperin I. J. et al. Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline. Canadian Journal of Diabetes, 2025.

Diabetes Canada Clinical Practice Guidelines Expert Working Group. Hypoglycemia in Adults. Canadian Journal of Diabetes, 2023.

Tobe S. W. et al. Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline. Canadian Journal of Diabetes, 2025.

Diabetes Control and Complications Trial Research Group. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine, 1993.

Government of British Columbia. BC PharmaCare: Diabetes Management. Updated 2026.

Shapiro A. M. J. et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen. New England Journal of Medicine, 2000.

Reichman T. W. et al. Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes. New England Journal of Medicine, 2025.

BC Diabetes. Islet Cell Transplant Studies. April 9, 2026. PDF.

Carlsson P.-O. et al. Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression. New England Journal of Medicine, 2025.